UnitedHealthcare
Jakafi (ruxolitinib)
Drugs for Cancer : Drugs for Cancer
  • PA Applies
  • Kidney Cancer:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Drug Policy Based On: NCCN Guidelines
    ECOG Score Requirement Included in Policy: N/A
    Policy Includes Reference to Coverage for Non Clear Cell Histology: No
    If Non-Clear Cell Histology is Referenced in Policy is There a Trial and Failure Requirement: No

  • Minimum Age: 3 Years; Maximum Age: N.A.;
  • Quantity Limit: 8 patches per 28 day(s).
  • Prior Authorization: Diabetic Medical Supplies:
    Documented Diagnosis: Yes
    Duration: 1 plan year
    Reauthorization Required: Yes